|
🐜
|
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
51 auth.
J. Alpert,
E. Antman,
F. Apple,
P. Armstrong,
J. Bassand,
A. D. Luna,
G. Beller,
G. Breithardt,
B. Chaitman,
P. Clemmensen,
E. Falk,
M. Fishbein,
M. Galvani,
A. Garson,
C. Grines,
...
C. Hamm,
U. Hoppe,
A. Jaffe,
H. Katus,
J. Kjekshus,
W. Klein,
P. Klootwijk,
C. Lenfant,
D. Levy,
R. Levy,
R. Luepker,
F. Marcus,
U. Naslund,
M. Ohman,
O. Pahlm,
P. Poole‐Wilson,
R. Popp,
K. Pyôrâlà,
J. Ravkilde,
N. Rehnquist,
W. Roberts,
R. Roberts,
J. Roelandt,
L. Rydén,
S. Sans,
M. Simoons,
K. Thygesen,
H. Tunstall-Pedoe,
R. Underwood,
B. Uretsky,
F. Werf,
L. Voipio‐Pulkki,
G. Wagner,
L. Wallentin,
W. Wijns,
D. Wood
|
12 |
2000 |
12
🐜
|
|
🐜
|
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
52 auth.
J. Alpert,
E. Antman,
F. Apple,
P. Armstrong,
J. Bassand,
A. Luna,
G. Beller,
G. Breithardt,
B. Chaitman,
P. Clemmensen,
E. Falk,
M. Fishbein,
M. Galvani,
A. Garson,
C. Grines,
...
C. Hamm,
B. Nauheim,
U. Hoppe,
A. Jaffe,
H. Katus,
J. Kjeksus,
W. Klein,
P. Klootwijk,
C. Lenfant,
D. Levy,
R. Levy,
R. Luepker,
F. Marcus,
U. Naslund,
M. Ohman,
O. Pahlm,
P. Poole‐Wilson,
R. Popp,
K. Pyôrâlà,
J. Ravkilde,
N. Rehnquist,
W. Roberts,
R. Roberts,
J. Roelandt,
L. Rydén,
S. Sans,
M. Simoons,
K. Thygesen,
H. Tunstall-Pedoe,
R. Underwood,
B. Uretsky,
F. Werf,
L. Voipio‐Pulkki,
G. Wagner,
L. Wallentin,
W. Wijns,
D. Wood
|
11 |
2000 |
11
🐜
|
|
🐜
|
A risk score to predict bleeding in patients with acute coronary syndromes.
15 auth.
R. Mehran,
S. Pocock,
E. Nikolsky,
T. Clayton,
G. Dangas,
A. Kirtane,
H. Parise,
M. Fahy,
S. Manoukian,
F. Feit,
...
M. Ohman,
B. Witzenbichler,
G. Guagliumi,
A. Lansky,
G. Stone
|
9 |
2010 |
9
🐜
|
|
🐜
|
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
12 auth.
G. Stone,
M. Bertrand,
A. Colombo,
G. Dangas,
M. Farkouh,
F. Feit,
...
A. Lansky,
A. Lincoff,
R. Mehran,
J. Moses,
M. Ohman,
H. White
|
7 |
2004 |
7
🐜
|
|
🐜
|
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
31 auth.
R. Page,
J. Joglar,
M. A. Caldwell,
S. Hammill,
H. Calkins,
J. Indik,
J. Conti,
B. Lindsay,
B. Deal,
B. Olshansky,
A. M. Estes,
A. Russo,
M. Field,
W. Shen,
Z. Goldberger,
...
C. Tracy,
S. Al‐Khatib,
G. Levine,
Jeffrey L. Anderson,
M. Hlatky,
J. Ikonomidis,
K. Birtcher,
B. Bozkurt,
R. Kovacs,
R. Brindis,
M. Ohman,
J. Cigarroa,
S. Pressler,
L. Curtis,
L. Fleisher,
Federico Gentile
|
7 |
2016 |
7
🐜
|
|
🐜
|
Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events.
10 auth.
D. Diercks,
M. Roe,
A. Chen,
W. Peacock,
J. Kirk,
C. Pollack,
...
W. Gibler,
Sidney C. Smith,
M. Ohman,
E. Peterson
|
7 |
2007 |
7
🐜
|
|
🐢
|
Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device
7 auth.
W. O’Neill,
C. Grines,
T. Schreiber,
J. Moses,
Brijeshwar Maini,
S. Dixon,
...
M. Ohman
|
7 |
2018 |
7
🐢
|
|
🦁
|
Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation.
M. Ohman,
Catherine Casey,
J. Bengtson,
D. Pryor,
W. Tormey,
J. Horgan
|
6 |
1990 |
6
🦁
|
|
🐜
|
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
12 auth.
G. Dangas,
A. Kini,
Samin K. Sharma,
J. Henriques,
B. Claessen,
S. Dixon,
...
J. Massaro,
I. Palacios,
J. Popma,
M. Ohman,
G. Stone,
W. O’Neill
|
6 |
2014 |
6
🐜
|
|
🐜
|
Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes.
9 auth.
N. LaPointe,
A. Chen,
K. Alexander,
M. Roe,
C. Pollack,
B. Lytle,
...
M. Ohman,
B. Gibler,
E. Peterson
|
6 |
2007 |
6
🐜
|
|
🐜
|
Flow Cytometric Monitoring of Glycoprotein IIb/IIIa Blockade and Platelet Function in Patients With Acute Myocardial Infarction Receiving Reteplase, Abciximab, and Ticlopidine: Continuous Platelet Inhibition by the Combination of Abciximab and Ticlopidine
10 auth.
K. Peter,
B. Kohler,
A. Straub,
J. Ruef,
M. Moser,
T. Nordt,
...
M. Olschewski,
M. Ohman,
W. Kübler,
C. Bode
|
5 |
2000 |
5
🐜
|
|
🐜
|
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis
8 auth.
William J. Gibson,
William J. Gibson,
Tarek Nafee,
R. Travis,
M. Yee,
M. Kerneis,
...
M. Ohman,
C. Gibson
|
5 |
2019 |
5
🐜
|
|
🐜
|
Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry.
11 auth.
C. Melloni,
B. Shah,
B. Shah,
F. Ou,
M. Roe,
Sidney C. Smith,
...
C. Pollack,
M. Ohman,
W. Gibler,
E. Peterson,
K. Alexander
|
5 |
2010 |
5
🐜
|
